PMID- 25592977 OWN - NLM STAT- MEDLINE DCOM- 20150730 LR - 20220311 IS - 1872-7123 (Electronic) IS - 0165-1781 (Linking) VI - 225 IP - 3 DP - 2015 Feb 28 TI - Changes in brain-derived neurotrophic factor (BDNF) during abstinence could be associated with relapse in cocaine-dependent patients. PG - 309-14 LID - S0165-1781(14)01012-9 [pii] LID - 10.1016/j.psychres.2014.12.019 [doi] AB - Brain-derived neurotrophic factor (BDNF) is involved in cocaine craving in humans and drug seeking in rodents. Based on this, the aim of this study was to explore the possible role of serum BDNF in cocaine relapse in abstinent addicts. Forty cocaine dependent subjects (DSM-IV criteria) were included in an inpatient 2 weeks abstinence program. Organic and psychiatric co-morbidities were excluded. Two serum samples were collected for each subject at baseline and at after 14 abstinence days. After discharge, all cocaine addicts underwent a 22 weeks follow-up, after which they were classified into early relapsers (ER) (resumed during the first 14 days after discharge,) or late relapsers (LR) (resumed beyond 14 days after discharge). The only clinical differences between groups were the number of consumption days during the last month before detoxification. Serum BDNF levels increased significantly across the 12 days of abstinence in the LR group (p=0.02), whereas in the ER group BDNF remained unchanged. In the ER group, the change of serum BDNF during abstinence negatively correlated with the improvement in depressive symptoms (p=0.02). These results suggest that BDNF has a role in relapse to cocaine consumption in abstinent addicts, although the underlying neurobiological mechanisms remain to be clarified. CI - Copyright (c) 2014 Elsevier Ireland Ltd. All rights reserved. FAU - Corominas-Roso, Margarida AU - Corominas-Roso M AD - Department of Psychiatry, Vall d׳Hebron University Hospital (CIBERSAM), Universitat Autonoma de Barcelona, Barcelona, Catalonia, Spain. Electronic address: mcoromin@vhebron.net. FAU - Roncero, Carlos AU - Roncero C AD - Department of Psychiatry, Vall d׳Hebron University Hospital (CIBERSAM), Universitat Autonoma de Barcelona, Barcelona, Catalonia, Spain; Biomedical Network Research Center on Mental Health (CIBERSAM), Madrid, Spain; Department of Psychiatry and Legal Medicine, Universitat Autonoma de Barcelona, Catalonia, Spain. FAU - Daigre, Constanza AU - Daigre C AD - Department of Psychiatry, Vall d׳Hebron University Hospital (CIBERSAM), Universitat Autonoma de Barcelona, Barcelona, Catalonia, Spain. FAU - Grau-Lopez, Lara AU - Grau-Lopez L AD - Department of Psychiatry, Vall d׳Hebron University Hospital (CIBERSAM), Universitat Autonoma de Barcelona, Barcelona, Catalonia, Spain; Department of Psychiatry and Legal Medicine, Universitat Autonoma de Barcelona, Catalonia, Spain. FAU - Ros-Cucurull, Elena AU - Ros-Cucurull E AD - Department of Psychiatry, Vall d׳Hebron University Hospital (CIBERSAM), Universitat Autonoma de Barcelona, Barcelona, Catalonia, Spain; Department of Psychiatry and Legal Medicine, Universitat Autonoma de Barcelona, Catalonia, Spain. FAU - Rodriguez-Cintas, Laia AU - Rodriguez-Cintas L AD - Department of Psychiatry, Vall d׳Hebron University Hospital (CIBERSAM), Universitat Autonoma de Barcelona, Barcelona, Catalonia, Spain. FAU - Sanchez-Mora, Cristina AU - Sanchez-Mora C AD - Department of Psychiatry, Vall d׳Hebron University Hospital (CIBERSAM), Universitat Autonoma de Barcelona, Barcelona, Catalonia, Spain; Biomedical Network Research Center on Mental Health (CIBERSAM), Madrid, Spain; Psychiatric Genetics Unit, Vall d׳Hebron Research Institute (VHIR), Barcelona, Catalonia, Spain. FAU - Lopez, Maria Victoria AU - Lopez MV AD - Department of Psychiatry, Vall d׳Hebron University Hospital (CIBERSAM), Universitat Autonoma de Barcelona, Barcelona, Catalonia, Spain. FAU - Ribases, Marta AU - Ribases M AD - Department of Psychiatry, Vall d׳Hebron University Hospital (CIBERSAM), Universitat Autonoma de Barcelona, Barcelona, Catalonia, Spain; Biomedical Network Research Center on Mental Health (CIBERSAM), Madrid, Spain; Psychiatric Genetics Unit, Vall d׳Hebron Research Institute (VHIR), Barcelona, Catalonia, Spain. FAU - Casas, Miguel AU - Casas M AD - Department of Psychiatry, Vall d׳Hebron University Hospital (CIBERSAM), Universitat Autonoma de Barcelona, Barcelona, Catalonia, Spain; Biomedical Network Research Center on Mental Health (CIBERSAM), Madrid, Spain; Department of Psychiatry and Legal Medicine, Universitat Autonoma de Barcelona, Catalonia, Spain. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20141220 PL - Ireland TA - Psychiatry Res JT - Psychiatry research JID - 7911385 RN - 0 (Brain-Derived Neurotrophic Factor) RN - I5Y540LHVR (Cocaine) SB - IM MH - Adolescent MH - Adult MH - Brain-Derived Neurotrophic Factor/*blood MH - Chronic Disease MH - *Cocaine MH - Cocaine-Related Disorders/*blood/psychology MH - Depression/blood/psychology MH - *Drug-Seeking Behavior MH - Female MH - Humans MH - Male MH - Middle Aged MH - Recurrence MH - Substance Withdrawal Syndrome/*blood/psychology MH - Young Adult OTO - NOTNLM OT - Abstinence OT - BDNF OT - Brain derived neurotrophic factor OT - Cocaine OT - Relapse EDAT- 2015/01/17 06:00 MHDA- 2015/08/01 06:00 CRDT- 2015/01/17 06:00 PHST- 2014/03/12 00:00 [received] PHST- 2014/12/06 00:00 [revised] PHST- 2014/12/14 00:00 [accepted] PHST- 2015/01/17 06:00 [entrez] PHST- 2015/01/17 06:00 [pubmed] PHST- 2015/08/01 06:00 [medline] AID - S0165-1781(14)01012-9 [pii] AID - 10.1016/j.psychres.2014.12.019 [doi] PST - ppublish SO - Psychiatry Res. 2015 Feb 28;225(3):309-14. doi: 10.1016/j.psychres.2014.12.019. Epub 2014 Dec 20.